ABSTRACT
Identifying critically ill patients who are likely to improve their respiratory physiology following RBC blood transfusion is dynamic and difficult. Current decision tools are over-reliant on hemoglobin transfusion thresholds, without considering respiratory measures that may reflect physiologic effects of anemia and functional responses to RBC transfusion. Further, routine clinical measures to determine transfusion efficacy beyond hemoglobin increment are lacking to identify patients as responders or non-responders. We present a two-center retrospective cohort study aiming to determine a potential biomarker to assess the physiologic response of RBC transfusion for ICU patients. The study was performed with 13,274 eligible admissions at the first center. Another 3,757 from the second center were used for validation purpose. We introduced a comparative analysis of two respiratory measures, SpO2 and SpO2/FiO2 (SF) ratio, in addition to hemoglobin, to assess individual patient responses to RBC transfusion. A statistical study was performed to analyze the change in these markers before and after the transfusion interval. Based on quantitative statistical analyses, we found SF ratio to be a more effective biomarker than hemoglobin alone for revealing RBC transfusion efficacy. There existed an inverse correlation between pre-transfusion SF and transfusion efficacy. The results were consistent across both centers, revealing generalizability.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
R Kamaleswaran and T Choudhary were supported by the National Institutes of Health under Award Numbers R01GM139967, R21GM151703, and R21GM14893.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Emory University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
E-mail addresses: geoffrey.smith{at}emory.edu (Geoffrey Smith), jroback{at}emory.edu (John D. Roback), rmpatel{at}emory.edu (Ravi M. Patel), cjoseph{at}emory.edu (Cassandra D. Josephson), r.kamaleswaran{at}duke.edu (Rishikesan Kamaleswaran)
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
